Characterization of an influenza A and influenza B co-infection of a patient in a long-term care facility with co-circulating influenza A and influenza B

International Journal of Infectious Diseases

Volumn 13, Issue 3, 2009, Pages

  Eshaghi, AliReza ^a   Blair, Joanne ^a   Burton, Laura ^a   Choi, Kam Wing ^a   De Lima, Cedric ^a   Duncan, Carla ^a   Guyard, Cyril ^a,b   Higgins, Rachel ^a   Lombos, Ernesto ^a   Low, Donald E ^a,b,c   Mazzulli, Tony ^a,b,c   Drews, Steven J ^a,b,c  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Co infection; Influenza; Outbreak; Strains

Indexed keywords

ADAMANTANE; OSELTAMIVIR;

ANTIBIOTIC RESISTANCE; CIRCULATION; CLINICAL FEATURE; DISEASE PREDISPOSITION; FLUORESCENT ANTIBODY TECHNIQUE; GENE MUTATION; HEALTH CARE PERSONNEL; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LETTER; LONG TERM CARE; REAL TIME POLYMERASE CHAIN REACTION;

DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; GENOTYPE; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; LONG-TERM CARE; ONTARIO; RESIDENTIAL FACILITIES;

EID: 64649101125     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.06.024     Document Type: Letter

References (10)

1. Falchi A., Arena C., Andreoletti L., Jacques J., Leveque N., Blanchon T., et al. Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. J Clin Virol 41 (2008) 148-151
2. Tobita K., and Ohori K. Heterotypic interference between influenza viruses A/Aichi/2/68 and B/Massachusetts/1/71. Acta Virol 23 (1979) 263-266
3. Katinger D., Romanova J., Ferko B., Fekete H., and Egorov A. Effect of a single mutation in neuraminidase on the properties of influenza B virus isolates. Arch Virol 149 (2004) 173-181
4. Takao S., Shimazu Y., Fukuda S., Kuwayama M., and Miyazaki K. Neuraminidase subtyping of human influenza a viruses by RT-PCR and its application to clinical isolates. Jpn J Infect Dis 55 (2002) 204-205
5. Wright K.E., Wilson G.A., Novosad D., Dimock C., Tan D., and Weber J.M. Typing and subtyping of influenza viruses in clinical samples by PCR. J Clin Microbiol 33 (1995) 1180-1184
6. Zou S. A practical approach to genetic screening for influenza virus variants. J Clin Microbiol 35 (1997) 2623-2627
7. Jackson D., Barclay W., and Zurcher T. Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. J Antimicrob Chemother 55 (2005) 162-169
8. Yen H.L., Herlocher L.M., Hoffmann E., Matrosovich M.N., Monto A.S., Webster R.G., et al. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother 49 (2005) 4075-4084
9. Bright R.A., Medina M.J., Xu X., Perez-Oronoz G., Wallis T.R., Davis X.M., et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366 (2005) 1175-1181
10. European Centre for Disease Prevention and Control. Emergence of seasonal influenza viruses type A (H1N1) with oseltamivir resistance in some European Countries at the start of the 2007-2008 influenza season. 1-11. 2008, http://ecdc.europa.eu/pdf/080127_os.pdf.